Clinical Trials Logo

Clinical Trial Summary

The goal of this research is to identify an intervention that will improve cognition and sleep in persons with PD.


Clinical Trial Description

Persons with Parkinson's disease (PD) often experience non-motor symptoms such as cognitive dysfunction and sleep problems. These symptoms can be more disabling than the motor symptoms of PD. Medications are often not effective for treating these non-motor symptoms or can have unwanted side effects. Non- medication treatments such as exercise are known to improve the motor symptoms of PD, but the effect of exercise on cognition and sleep has not been fully explored. This study investigates the impact of 16 weeks of supervised exercise, 3 times per week, compared to no-exercise over the same duration, on cognition and sleep dysfunction. Participants will be evaluated with cognitive tests and sleep studies before and after 16-weeks to determine the impact of this exercise intervention. The goal of this research is to identify an intervention that will improve cognition and sleep in persons with PD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03495193
Study type Interventional
Source University of Alabama at Birmingham
Contact Amy Amara, MD, PhD
Phone 205-934-0683
Email amyamara@uabmc.edu
Status Recruiting
Phase N/A
Start date May 18, 2017
Completion date May 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Not yet recruiting NCT03618901 - Rock Steady Boxing vs. PD SAFEx N/A
Not yet recruiting NCT03664609 - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Recruiting NCT03257046 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease Phase 1/Phase 2
Recruiting NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Completed NCT03103399 - Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon Phase 2
Recruiting NCT03104725 - Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? N/A
Recruiting NCT03014050 - Bio Electro Stimulation Therapy for Parkinson's Disease N/A
Not yet recruiting NCT03575195 - Microbiota Intervention to Change the Response of Parkinson's Disease Phase 1/Phase 2
Not yet recruiting NCT03648749 - Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease N/A
Not yet recruiting NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Not yet recruiting NCT03551392 - Pilot Intervention With Near Infrared Stimulation N/A
Not yet recruiting NCT03582371 - Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK) N/A
Recruiting NCT03192046 - Bracing for Walking in Parkinson's Disease N/A
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Recruiting NCT02601586 - Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease Phase 2/Phase 3
Recruiting NCT03045211 - Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson Disease N/A
Recruiting NCT02823158 - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM N/A